Heron Therapeutics Inc. | Ownership
Companies that own Heron Therapeutics Inc.
Fidelity Management & Research Co.
11,276,956
14.51%
743,699
0.04%
06/30/2018
Tang Capital Management LLC
8,647,398
11.12%
-854
45.09%
06/30/2018
Franklin Advisers, Inc.
5,920,672
7.62%
-1,095,694
0.15%
06/30/2018
Henderson Global Investors Ltd.
5,870,810
7.55%
-2,150,540
0.1%
06/30/2018
Baker Bros. Advisors LP
5,025,298
6.47%
0
1.26%
06/30/2018
Wellington Management Co. LLP
4,770,175
6.14%
2,597,229
0.03%
06/30/2018
The Vanguard Group, Inc.
4,402,737
5.66%
1,702,252
0.01%
06/30/2018
BlackRock Fund Advisors
3,893,940
5.01%
770,035
0.01%
06/30/2018
SSgA Funds Management, Inc.
3,466,886
4.46%
323,336
0.01%
06/30/2018
ArrowMark Colorado Holdings LLC
2,218,376
2.85%
-149,546
0.77%
06/30/2018
| Address |
4242 Campus Point Court
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.herontx.com |
| Updated |
07/08/2019 |
| Heron Therapeutics, Inc. is a biotechnology company, which develops pharmaceutical products for patients suffering from cancer. The company develops products by using its proprietary Biochronomer polymer based drug delivery technology. Its products include SUSTOL, Pipeline, Cinvanti and HTX-011. |
